Company profile
Amlo Biosciences company profile
AMLo Biosciences has identified two proteins (AMBLor™) in the skin overlying the primary tumour that are lost in high-risk melanoma.
Business identity
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0-$1M
- Founded
- 2017-01-01, Year
Headquarters
- Headquarters
- Newcastle upon Tyne, England, United Kingdom
- Country code
- GB
- Continent
- Europe